Javascript must be enabled to continue!
Supplementary Figures 1 - 6 from ATP Citrate Lyase Mediates Resistance of Colorectal Cancer Cells to SN38
View through CrossRef
<p>PDF file - 840K, Suppl. Figure 1. Conversion of CPT-11 (irinotican) to SN-38 by carboxylesterase; Suppl. Figure 2. Western blot analysis of the basal expression status of ACLy in a panel of colon cancer cell (CRC) lines; Suppl. Figure 3. Overexpression of fatty acid synthase (FASN) inhibited ACLy inhibition induced sensitization of HT29 cells to SN38; Suppl. Figure 4. Increased lipid droplets in HT29 cells that are resistant to SN38 (HT29-SNR) or oxaliplatin (HT29-OxR); Suppl. Figure 5. HT29-SNR cells exhibited enhanced de novo lipogenesis; Suppl. Figure 6. Co-targeting ACLy and AKT re-sensitized HT29-SNR cells to SN38.</p>
American Association for Cancer Research (AACR)
Title: Supplementary Figures 1 - 6 from ATP Citrate Lyase Mediates Resistance of Colorectal Cancer Cells to SN38
Description:
<p>PDF file - 840K, Suppl.
Figure 1.
Conversion of CPT-11 (irinotican) to SN-38 by carboxylesterase; Suppl.
Figure 2.
Western blot analysis of the basal expression status of ACLy in a panel of colon cancer cell (CRC) lines; Suppl.
Figure 3.
Overexpression of fatty acid synthase (FASN) inhibited ACLy inhibition induced sensitization of HT29 cells to SN38; Suppl.
Figure 4.
Increased lipid droplets in HT29 cells that are resistant to SN38 (HT29-SNR) or oxaliplatin (HT29-OxR); Suppl.
Figure 5.
HT29-SNR cells exhibited enhanced de novo lipogenesis; Suppl.
Figure 6.
Co-targeting ACLy and AKT re-sensitized HT29-SNR cells to SN38.
</p>.
Related Results
Data from ATP Citrate Lyase Mediates Resistance of Colorectal Cancer Cells to SN38
Data from ATP Citrate Lyase Mediates Resistance of Colorectal Cancer Cells to SN38
<div>Abstract<p>Combination chemotherapy is standard for metastatic colorectal cancer; however, nearly all patients develop drug resistance. Understanding the mechanism...
Data from ATP Citrate Lyase Mediates Resistance of Colorectal Cancer Cells to SN38
Data from ATP Citrate Lyase Mediates Resistance of Colorectal Cancer Cells to SN38
<div>Abstract<p>Combination chemotherapy is standard for metastatic colorectal cancer; however, nearly all patients develop drug resistance. Understanding the mechanism...
Impact of Common Anticoagulants on Complete Blood Count Parameters Among Humans
Impact of Common Anticoagulants on Complete Blood Count Parameters Among Humans
Abstract
Introduction
Among the most frequently used anticoagulants in hematological testing are tetra-acetic acid (EDTA), sodium citrate, and sodium heparin. However, there is a n...
Abstract 5758: Single protein encapsulated SN38: Extremely effective anticancer drug with low toxicity
Abstract 5758: Single protein encapsulated SN38: Extremely effective anticancer drug with low toxicity
Abstract
Purpose:
SN38 is a potent antineoplastic agent, however, the poor water solubility prohibited its direct clinica...
The Acyl‐Carrier Protein of Citrate Lyase
The Acyl‐Carrier Protein of Citrate Lyase
When [14C]acetyl citrate lyase was dissociated in sodium dodecylsulfate and the products were separated by gel electrophoresis, all of the radioactive label appeared in a small pro...
Abstract A13: Applied the proteomics characteristics to detect the inherited colorectal adenomas
Abstract A13: Applied the proteomics characteristics to detect the inherited colorectal adenomas
Abstract
Introduction: Current study found that about one-third of the incidence of colorectal cancer have genetic related. Hereditary nonpolyposis colorectal cancer...
MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing v1
MARS-seq2.0: an experimental and analytical pipeline for indexed sorting combined with single-cell RNA sequencing v1
Human tissues comprise trillions of cells that populate a complex space of molecular phenotypes and functions and that vary in abundance by 4–9 orders of magnitude. Relying solely ...
Supplementary Figures S1-S25 from Late-stage metastatic melanoma emerges through a diversity of evolutionary pathways
Supplementary Figures S1-S25 from Late-stage metastatic melanoma emerges through a diversity of evolutionary pathways
<p>Supplementary figure 1: Cohort overview. Number of samples sequenced with whole exome, panel or whole
RNA sequencing.
Supplementary figure 2: Phylogeny and WGD events in ...

